5-HT Receptor Antagonists for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Comparison of Their Pharmacology and Clinical Efficacy

Author： Gregory R.E.   Ettinger D.S.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.55, Iss.2, 1998-02, pp. : 173-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Review of palonosetron: emerging data distinguishing it as a novel 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting

By Saito Mitsue   Tsukuda Mamoru  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 6, 2010-04 ,pp. : 1003-1014

Informa Healthcare

Access to resources Recommend Favorite

Tachykinin NK1 receptor antagonists for the control of chemotherapy-induced nausea and vomiting

By Gale Jeremy D   O’Neill Brian T   Humphrey John M  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 12, 2001-12 ,pp. : 1837-1847

Informa Healthcare

Access to resources Recommend Favorite

Fosaprepitant (MK-0517): a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting

By Navari Rudolph M  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 12, 2007-12 ,pp. : 1977-1985

Informa Healthcare

Access to resources Recommend Favorite

Risk–benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting

By Herrstedt Jørn  

Expert Opinion on Drug Safety, Vol. 3, Iss. 3, 2004-05 ,pp. : 231-248

Informa Healthcare

Access to resources Recommend Favorite

Safety evaluation of aprepitant for the prevention of chemotherapy-induced nausea and vomiting

By Ruhlmann Christina H   Herrstedt Jøørn  

Expert Opinion on Drug Safety, Vol. 10, Iss. 3, 2011-05 ,pp. : 449-462

Informa Healthcare

Access to resources Recommend Favorite